<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04891081</url>
  </required_header>
  <id_info>
    <org_study_id>0000</org_study_id>
    <nct_id>NCT04891081</nct_id>
  </id_info>
  <brief_title>Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease</brief_title>
  <official_title>Plasma Metanephrines in Patients With Cyanotic and Acyanotic Congenital Heart Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Medical Centre Ljubljana</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>University of Ljubljana, Faculty of Medicine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University Rehabilitation Institute, Republic of Slovenia</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University Medical Centre Ljubljana</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of our study is to compare plasma metanephrines in patients with cyanotic and&#xD;
      acyanotic congenital heart disease and possible association with chronic hypoxic stress.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 1, 2019</start_date>
  <completion_date type="Anticipated">June 9, 2021</completion_date>
  <primary_completion_date type="Anticipated">May 31, 2021</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>5 Years</target_duration>
  <primary_outcome>
    <measure>Plasma metanephrine level</measure>
    <time_frame>baseline, one point of time in a cross-sectional study</time_frame>
    <description>Level of plasma metanephrine</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Plasma normetanephrine level</measure>
    <time_frame>baseline, one point of time in a cross-sectional study</time_frame>
    <description>Level of plasma normetanephrine</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Hypoxemia</measure>
    <time_frame>baseline, one point of time in a cross-sectional study</time_frame>
    <description>Length of hypoxemia presence in years</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Acyanotic Congenital Heart Disease</condition>
  <condition>Cyanotic Congenital Heart Disease</condition>
  <condition>Pheochromocytoma</condition>
  <condition>Paraganglioma</condition>
  <arm_group>
    <arm_group_label>Patients with cyanotic Congenital Heart Disease</arm_group_label>
  </arm_group>
  <arm_group>
    <arm_group_label>Patients with acyanotic Congenital Heart Disease</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        Adult patients with congenital heart disease attending regular follow ups.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  patients with congenital heart disease attending regular follow up&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  missing main data in medical documentation&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Mojca Jensterle, MD, PhD</last_name>
    <phone>03861 522 35 64</phone>
    <email>mojca.jensterlesever@kclj.si</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Internal Medicine, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia</name>
      <address>
        <city>Ljubljana</city>
        <zip>1000</zip>
        <country>Slovenia</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mojca Jensterle, MD, PhD</last_name>
      <phone>0o3861 522 50 5</phone>
      <email>mojca.jensterlesever@kclj.si</email>
    </contact>
  </location>
  <location_countries>
    <country>Slovenia</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>May 10, 2021</study_first_submitted>
  <study_first_submitted_qc>May 13, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 18, 2021</study_first_posted>
  <last_update_submitted>May 13, 2021</last_update_submitted>
  <last_update_submitted_qc>May 13, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Medical Centre Ljubljana</investigator_affiliation>
    <investigator_full_name>Mojca Jensterle</investigator_full_name>
    <investigator_title>Clinical Professor, MD, PhD</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pheochromocytoma</mesh_term>
    <mesh_term>Paraganglioma</mesh_term>
    <mesh_term>Carotid Body Tumor</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
    <mesh_term>Heart Defects, Congenital</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

